Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. May 28, 2020; 26(20): 2645-2656
Published online May 28, 2020. doi: 10.3748/wjg.v26.i20.2645
Figure 2
Figure 2 The frequency of B cell-activating factor receptors expression was significantly lower in patients with hepatocellular carcinoma compared with the other groups. Representative fluorescence activated cell sorting and statistic plots of A: B cell-activating factor receptors; B: Transmembrane activator and cyclophilin ligand interactor; C: B-cell maturation antigen. TACI: Transmembrane activator and cyclophilin ligand interactor; BCMA: B-cell maturation antigen; BAFF-R: B cell-activating factor receptors; HCC: Hepatocellular carcinoma; HC: Healthy controls.